Supervised exercises at home may safely improve motor function and quality of life in people with mild to moderate Parkinson’s disease, a study in China suggests. The benefits were seen both with sessions conducted by a physical therapist at patients’ homes and with telerehabilitation using an application with predetermined…
A clinical trial testing the safety and tolerability of Brenig Therapeutics‘ BT-267, a potential disease-modifying therapy for Parkinson’s due to an unknown cause — known as idiopathic — or disease associated with LRRK2 gene mutations, has begun dosing healthy volunteers. Following this initial assessment — the first-in-human trial of…
Ochsner Health, a healthcare provider in the U.S. Gulf South, has been named one of six new study sites by the Global Parkinson’s Genetics Program (GP2), which is studying the genetic basis of Parkinson’s disease among underrepresented populations. Increased genetic knowledge of these populations may support the…
Angels on Call, a home care services provider, has been granted Certified Parkinson Disease Care (CPDC) accreditation by the Parkinson’s and Movement Disorders Alliance (PMD Alliance). The agency became the first in its field to earn the certification in the U.S. The accreditation involves training staff to…
CND Life Sciences has been awarded a $4.2 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) toward a study that will evaluate the use of an alpha-synuclein skin test to aid in diagnosing Parkinson’s disease and tracking its progression. The Syn-Q clinical trial…
For a 69-year-old man with advanced Parkinson’s disease, sleeping with the head of his bed elevated helped to decrease dizziness related to a sudden drop in blood pressure when he got up in the morning, according to a case reported in the Netherlands. This drop in blood pressure is…
A Phase 3 clinical trial evaluating investigational oral therapy solengepras as a treatment for Parkinson’s disease has dosed its first patient. The ARISE trial (NCT06553027) is evaluating the efficacy of solengepras as a potential add-on therapy to levodopa and other Parkinson’s medications. Patient recruitment is ongoing…
Vivolta and Neurochase have partnered to manufacture specialized micro-catheters using the former’s medical electrospinning (MediSpin) technology to deliver therapies directly to specific brain regions for neurological conditions like Parkinson’s disease. The technology would enhance Neurochase’s Convection Enhanced Delivery (CED) system, which is designed to allow…
ACI-7104, an investigational vaccine to treat people in the early stages of Parkinson’s disease, is showing safety and tolerability in a Phase 2 clinical trial, while also inducing the production of anti-alpha-synuclein antibodies at high levels, according to interim trial findings. Being developed by AC Immune,…
The Critical Path Institute (C-Path) is launching a new initiative to advance research on how Parkinson’s disease impacts women and people across the gender spectrum. The goal is to develop treatments and technologies that take into account each person’s unique experience with the disease, leading to more equitable approaches for…
Get regular updates to your inbox.
